ImmunityBio, Inc. (IBRX): Shares Outstanding
1.01B
As of 2025-12-31
1.05B
As of 2026-06-30
+33.9%
3-year compound annual growth
+21.5%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 1.01B | +18.6% | 2026-02-23, Balance as of period end |
| 2024-12-31 | 852.90M | +27.1% | 2026-02-23, Balance as of period end |
| 2023-12-31 | 670.87M | +59.1% | 2025-03-03, Balance as of period end |
| 2022-12-31 | 421.57M | +6.0% | 2024-03-19, Balance as of period end |
| 2021-12-31 | 397.83M | +4.1% | 2023-03-01, Balance as of period end |
| 2020-12-31 | 382.24M | n/c | 2022-03-01, Balance as of period end |
| 2019-12-31 | 98.46M | +24.5% | 2021-03-04, Balance as of period end |
| 2018-12-31 | 79.09M | +0.1% | 2020-03-25, Balance as of period end |
| 2017-12-31 | 79.02M | -3.6% | 2019-03-13, Balance as of period end |
| 2016-12-31 | 81.98M | +0.8% | 2018-03-12, Balance as of period end |
| 2015-12-31 | 81.31M | n/a | 2017-03-15, Balance as of period end |